Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,764 | -5,387 | -2,677 | -10,444 | -7,522 |
| Depreciation Amortization | 499 | 322 | 163 | 615 | 454 |
| Accounts payable and accrued liabilities | 999 | 874 | 314 | N/A | 334 |
| Other Working Capital | 1,343 | 1,336 | 304 | 212 | 33 |
| Other Operating Activity | 4,851 | -689 | -168 | 17 | -320 |
| Operating Cash Flow | $-6,072 | $-3,544 | $-2,064 | $-9,600 | $-7,021 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -540 | -416 | -55 | -233 | -166 |
| Investing Cash Flow | $-540 | $-416 | $-55 | $-233 | $-166 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 500 | 500 | N/A | N/A | 6,800 |
| Debt Repayment | -404 | -316 | -151 | N/A | -455 |
| Common Stock Issued | 7 | 3 | N/A | N/A | N/A |
| Other Financing Activity | 10,710 | 11,019 | 995 | 10,774 | 0 |
| Financing Cash Flow | $10,813 | $11,206 | $844 | $10,774 | $6,345 |
| Beginning Cash Position | 2,643 | 2,643 | 2,643 | 1,702 | 1,702 |
| End Cash Position | 6,844 | 9,889 | 1,368 | 2,643 | 860 |
| Net Cash Flow | $4,201 | $7,246 | $-1,275 | $941 | $-842 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,072 | -3,544 | -2,064 | -9,600 | -7,021 |
| Capital Expenditure | -540 | -416 | -55 | N/A | -166 |
| Free Cash Flow | -6,612 | -3,960 | -2,119 | -9,600 | -7,187 |